首页> 美国卫生研究院文献>Nucleic Acid Therapeutics >Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins
【2h】

Ligand-Guided Selection of Target-Specific Aptamers: A Screening Technology for Identifying Specific Aptamers Against Cell-Surface Proteins

机译:目标特异性适体的配体引导选择:一种针对细胞表面蛋白的特异性适体的筛选技术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report on a new strategy for identifying highly specific aptamers against a predetermined epitope of a target. Termed “ligand-guided selection” (LIGS), this method uniquely exploits the selection step, the core of SELEX (Systematic Evolution Exponential enrichment). LIGS uses a naturally occurring stronger and highly specific bivalent binder, an antibody (Ab) interacting with its cognate antigen to outcompete specific aptamers from a partially enriched SELEX pool, as a strategy. We demonstrate the hypothesis of LIGS by utilizing an Ab binding to membrane-bound Immunoglobulin M (mIgM) to selectively elute aptamers that are specific for mIgM from a SELEX pool that is partially enriched toward mIgM expressing Ramos cells. The selected aptamers show specificity toward Ramos cells. We identified three aptamer candidates utilizing LIGS that could be outcompeted by mIgM Ab, demonstrating that LIGS can be successfully applied to select aptamers from a partially evolved cell-SELEX library, against predetermined receptor proteins using a cognate ligand. This proof-of-concept study introduces a new biochemical-screening platform that exploits the binding of a secondary stronger molecular entity to its target as a partition step, to identify highly specific artificial nucleic acid ligands.
机译:我们报告了一种新策略,用于针对目标的预定表位识别高度特异性的适体。这种方法称为“配体引导选择”(LIGS),它独特地利用了选择步骤,即SELEX(系统进化指数富集)的核心。 LIGS使用一种天然存在的更强且高度特异性的二价结合剂(一种策略),即一种抗体(Ab)与其关联抗原相互作用,以与部分富集的SELEX库中的特异性适体竞争。我们通过利用与膜结合的免疫球蛋白M(mIgM)结合的Ab选择性地从部分向mIgM表达Ramos细胞富集的SELEX池中选择性洗脱特定于mIgM的适体的LIGS假说。所选的适体显示出对拉莫斯细胞的特异性。我们确定了三种利用LIGS的适体候选物,它们可能被mIgM Ab竞争,这表明LIGS可以成功地应用于应用同源配体针对预定的受体蛋白从部分进化的细胞SELEX文库中选择适体。这项概念验证研究引入了一个新的生化筛选平台,该平台利用次强分子实体与其靶标的结合作为分配步骤,以鉴定高度特异性的人工核酸配体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号